Jonathan Weiss / Shutterstock.com
The US Court of Appeals for the Federal Circuit affirmed a series of Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs), which upheld a patent owned by Eli Lilly late last week.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, PTAB, Alimta, chemotherapy, Neptune Generics, Mylan, Fresenius Kabi, US Court of Appeals for the Federal Circuit, IPRs